Says Medicare business one of the strongest growth segments. Sees 12% growth in Medicare Advantage business in 2023. Says growth in retail pharmacy is "notable." Says Signify Health and Oak Street Health acquisitions a "short term impact" to EPS growth. Comments taken from Q1 earnings conference call.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CVS:
- CVS Health raises FY23 revenue view to $348B-$353B from $332.7B-$338.5B
- CVS Health cuts FY23 adjusted EPS view to $8.50-$8.70 from $8.70-$8.90
- CVS Slips on Guidance Cut
- CVS Health reports Q1 adjusted EPS $2.20, consensus $2.09
- CVS HEALTH REPORTS FIRST QUARTER RESULTS, COMPLETES ACQUISITIONS OF SIGNIFY HEALTH AND OAK STREET HEALTH